Div­ing deep in­to AMD, Yale re­searchers pin­point cell types drug de­vel­op­ers should pay spe­cial at­ten­tion to

The wild suc­cess­es of drugs like Eylea and Lu­cen­tis some­times over­shad­ow the fact that there still isn’t a cure for age-re­lat­ed mac­u­lar de­gen­er­a­tion, the lead­ing …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER